Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Search for glaxo wellcome plc in registrations and monthly communication reports

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

Type
Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (51)
Results: 1-50 | Export
  1. GlaxoSmithKline
    Type: Consultant
    Lobbyist: MICHAEL VON HERFF, Fleishman-Hillard Canada Inc
    Registration: 2 of 2 (2007-07-27 to 2008-01-14)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
  2. GlaxoSmithKline
    Type: Consultant
    Lobbyist: RONALD GUIRGUIS, Fleishman-Hillard Canada Inc.
    Registration: 2 of 2 (2007-07-26 to 2008-01-15)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 5
    Government funding: No
  3. GlaxoSmithKline
    Type: Consultant
    Lobbyist: Kevin Macintosh, Fleishman-Hillard Canada Inc.
    Registration: 2 of 2 (2007-07-26 to 2007-10-19)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 5
    Government funding: No
  4. GlaxoSmithKline
    Type: Consultant
    Lobbyist: Terrance Oakey, FLEISHMAN-HILLARD CANADA INC.
    Registration: 2 of 2 (2007-07-25 to 2008-01-23)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 5
    Government funding: No
  5. GlaxoSmithKline
    Type: Consultant
    Lobbyist: Kevin Macintosh, Fleishman-Hillard Canada Inc.
    Registration: 1 of 2 (2007-05-22 to 2007-07-26)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 5
    Government funding: No
  6. GlaxoSmithKline
    Type: Consultant
    Lobbyist: Terrance Oakey, FLEISHMAN-HILLARD CANADA INC.
    Registration: 1 of 2 (2007-05-22 to 2007-07-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 5
    Government funding: No
  7. GlaxoSmithKline
    Type: Consultant
    Lobbyist: MICHAEL VON HERFF, Fleishman-Hillard Canada Inc
    Registration: 1 of 2 (2007-04-18 to 2007-07-27)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
  8. GlaxoSmithKline
    Type: Consultant
    Lobbyist: RONALD GUIRGUIS, Fleishman-Hillard Canada Inc.
    Registration: 1 of 2 (2007-04-18 to 2007-07-26)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 5
    Government funding: No
  9. GLAXOSMITHKLINE INC.
    Type: In-house Corporation
    Responsible officer: STEPHEN BROOKS, MANAGER, FEDERAL AFFAIRS & PUBLIC POLICY
    Registration: 1 of 1 (2005-05-24 to 2005-06-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 22
    Communication techniques: 6
    Government funding: No
  10. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BRYAN JONES, MANAGER, PUBLIC POLICY
    Registration: 2 of 2 (2005-01-06 to 2005-06-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 14
    Communication techniques: 6
    Government funding: No
  11. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BRYAN JONES, MANAGER, PUBLIC POLICY
    Registration: 1 of 2 (2004-11-22 to 2005-01-05)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 14
    Communication techniques: 6
    Government funding: No
  12. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: GRANT PERRY, DIRECTOR, FEDERAL AFFAIRS AND PUBLIC POLICY
    Registration: 7 of 7 (2004-01-30 to 2005-03-15)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  13. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: GRANT PERRY, DIRECTOR, FEDERAL AFFAIRS AND PUBLIC POLICY
    Registration: 6 of 7 (2004-01-28 to 2004-01-30)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  14. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BLAIR DICKERSON, EXTERNAL AFFAIRS
    Registration: 2 of 2 (2004-01-28 to 2005-03-21)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  15. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: CARL VIEL, DIRECTOR, EXTERNAL RELATIONS (EAST)
    Registration: 2 of 2 (2003-01-24 to 2004-03-19)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 19
    Communication techniques: 2
    Government funding: No
  16. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BLAIR DICKERSON, EXTERNAL AFFAIRS
    Registration: 1 of 2 (2003-01-24 to 2004-01-28)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  17. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: STEPHEN ALLAIN, MARKET ACCESS MANAGER
    Registration: 2 of 2 (2003-01-24 to 2004-03-19)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  18. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: GRANT PERRY, DIRECTOR, FEDERAL AFFAIRS AND PUBLIC POLICY
    Registration: 5 of 7 (2003-01-14 to 2004-01-28)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  19. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: STEPHEN ALLAIN, MARKET ACCESS MANAGER
    Registration: 1 of 2 (2002-11-21 to 2003-01-24)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  20. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: CARL VIEL, DIRECTOR, EXTERNAL RELATIONS (EAST)
    Registration: 1 of 2 (2002-11-21 to 2003-01-24)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 19
    Communication techniques: 2
    Government funding: No
  21. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: GRANT PERRY, DIRECTOR, FEDERAL AFFAIRS AND PUBLIC POLICY
    Registration: 4 of 7 (2002-02-12 to 2003-01-14)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  22. GLAXOSMITHKLINE
    Type: Consultant
    Lobbyist: CHRISTINA DE TONI, HILL AND KNOWLTON CANADA
    Registration: 1 of 1 (2001-10-05 to 2004-11-15)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 4
    Government funding: No
  23. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: CHRISTOPHER WHITE, PUBLIC AFFAIRS MANAGER
    Registration: 1 of 1 (2001-07-04 to 2002-02-07)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
  24. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: ANDREE GRAVEL, DIRECTRICE, AFFAIRES EXTERNES
    Registration: 6 of 6 (2001-01-30 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 5
    Government funding: No
  25. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: GRANT PERRY, DIRECTOR, FEDERAL AFFAIRS AND PUBLIC POLICY
    Registration: 3 of 7 (2001-01-29 to 2002-02-12)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  26. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: PAUL LUCAS, PRESIDENT & CEO
    Registration: 6 of 62 (2001-01-29 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  27. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: PAUL LUCAS, PRESIDENT & CEO
    Registration: 5 of 62 (2000-02-25 to 2001-01-29)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  28. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: GRANT PERRY, DIRECTOR, FEDERAL AFFAIRS AND PUBLIC POLICY
    Registration: 2 of 7 (2000-02-25 to 2001-01-29)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  29. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: SUZANNE CADDEN, DIRECTOR, REGULATORY AFFAIRS
    Registration: 4 of 4 (2000-02-25 to 2001-01-17)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 4
    Government funding: No
  30. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: MICHAEL LEVY, SENIOR V.P., MEDICAL SCIENCES & CHIEF MEDICAL OFFI
    Registration: 5 of 5 (2000-02-25 to 2001-01-17)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 6
    Government funding: No
  31. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: ANDREE GRAVEL, DIRECTRICE, AFFAIRES EXTERNES
    Registration: 5 of 6 (2000-01-31 to 2001-01-11)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 5
    Government funding: No
  32. GLAXOSMITHKLINE
    Type: Consultant
    Lobbyist: GRAHAM HARDMAN, HILL AND KNOWLTON CANADA
    Registration: 1 of 1 (1999-11-09 to 2005-02-23)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 4
    Government funding: No
  33. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: GRANT PERRY, DIRECTOR, FEDERAL AFFAIRS AND PUBLIC POLICY
    Registration: 1 of 7 (1999-07-20 to 2000-02-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  34. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: KATHLEEN OSBORNE, MANAGER, PUBLIC POLICY
    Registration: 1 of 1 (1999-02-01 to 2000-02-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 6
    Government funding: No
  35. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: MICHAEL LEVY, SENIOR V.P., MEDICAL SCIENCES & CHIEF MEDICAL OFFI
    Registration: 4 of 5 (1999-01-21 to 2000-02-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 6
    Government funding: No
  36. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BILL LAIDLAW, DIRECTOR, GOVERNMENT RELATIONS
    Registration: 4 of 4 (1999-01-21 to 2000-02-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  37. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: PAUL LUCAS, PRESIDENT & CEO
    Registration: 4 of 62 (1999-01-21 to 2000-02-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  38. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: SUZANNE CADDEN, DIRECTOR, REGULATORY AFFAIRS
    Registration: 3 of 4 (1999-01-21 to 2000-02-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 4
    Government funding: No
  39. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: RICHARD PRINGLE, DIRECTOR, CORPORATE AFFAIRS
    Registration: 1 of 1 (1998-03-06 to 1999-01-21)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 6
    Government funding: No
  40. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: ANDREE GRAVEL, DIRECTRICE, AFFAIRES EXTERNES
    Registration: 3 of 6 (1998-03-04 to 1999-02-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
  41. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: PAUL LUCAS, PRESIDENT & CEO
    Registration: 3 of 62 (1998-02-13 to 1999-01-21)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 13
    Communication techniques: 6
    Government funding: No
  42. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: SUZANNE CADDEN, DIRECTOR, REGULATORY AFFAIRS
    Registration: 2 of 4 (1998-02-13 to 1999-01-21)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 4
    Government funding: No
  43. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: MICHAEL LEVY, SENIOR V.P., MEDICAL SCIENCES & CHIEF MEDICAL OFFI
    Registration: 3 of 5 (1998-02-11 to 1999-01-21)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 6
    Government funding: No
  44. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BILL LAIDLAW, DIRECTOR, GOVERNMENT RELATIONS
    Registration: 3 of 4 (1998-02-11 to 1999-01-21)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  45. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: SUZANNE CADDEN, DIRECTOR, REGULATORY AFFAIRS
    Registration: 1 of 4 (1997-02-24 to 1998-02-13)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 4
    Government funding: No
  46. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BILL LAIDLAW, DIRECTOR, GOVERNMENT RELATIONS
    Registration: 2 of 4 (1997-02-04 to 1998-02-11)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  47. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: MICHAEL LEVY, SENIOR V.P., MEDICAL SCIENCES & CHIEF MEDICAL OFFI
    Registration: 2 of 5 (1997-02-03 to 1998-02-11)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 6
    Government funding: No
  48. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: MICHAEL LEVY, SENIOR V.P., MEDICAL SCIENCES & CHIEF MEDICAL OFFI
    Registration: 1 of 5 (1996-03-25 to 1997-02-03)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 6
    Government funding: No
  49. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: BILL LAIDLAW, DIRECTOR, GOVERNMENT RELATIONS
    Registration: 1 of 4 (1996-03-25 to 1997-02-04)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 6
    Government funding: No
  50. GLAXOSMITHKLINE
    Type: In-house Corporation
    Responsible officer: PAUL LUCAS, PRESIDENT & CEO
    Registration: 1 of 62 (1996-03-25 to 1997-02-04)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 6
    Government funding: No

Date Modified: